PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DIEASE (NDD-CKD) (PRO2TECT – CORRECTION) (Protocol # AKB-6548-CI-0014)

Study Details

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD

Learn More

ClinicalTrials.gov NCT number
NCT02648347

Principal Investigators

  • Eric Brown, MD
Contact
Maryanne Ducey, DC, RN at 203-358-8879
or officeofresearch@stamhealth.org